Sort   by:  
 Page size 
ProteomicsProtein Signatures to Distinguish Aggressive from Indolent Prostate Cancer
We performed a mass spectrometry-based proteomic analysis of normal and malignant prostate tissues from 22 men who underwent surgery for prostate cancer. Prostate cancer samples included Grade Groups (3 to 5), with 8 patients experiencing recurrence and 14 without evidence of recurrence with a mean ...
ORGANISM(S): Homo sapiens (Human) 
2022-05-04 | PXD028118 | Pride
Ctsd Psa Prostate cancer Calr Postn Recurrent Yy1 Biomarker Prognosis 
UnknownEvaluating The Accuracy Of Medicare Risk Adjustment For Alzheimer's Disease And Related Dementias.
Not available
S-EPMC9973227 | biostudies-literature
ProteomicsUCHL1 is a Molecular Indicator and a Therapeutic Target for Neuroendocrine Carcinomas
Quantitative proteomics analysis was performed on patient derived neuroendocrine tissue xenografts comparing sh control (N=2), and shUCHL1 (N=4), and in NCI-H660 cell line xenografts comparing control (N=3) and LDN-57444 treated (N=3). Each condition was injected in triplicate.
ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human) 
2023-12-03 | PXD044864 | Pride
Uchl1 Xenografts Prostate cancer Neuroendocrine carcinomas 
ProteomicsOncogene-Mediated Metabolic Gene Signature Predicts Breast Cancer Outcome
We performed shotgun protoemic analysis of tumor samples from HCC1806 shCtrl and shTrop2 xenograft mice.
ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human) 
2021-12-19 | PXD028335 | Pride
Proteomics Trop2 Breast cancer 
ProteomicsProteomics Analysis of Trop2 Xenograft Prostate Tumors
Shotgun proteomic analysis of LNCaP-Trop2-OV tumor xenografts and LNCaP-RFP control tumors
ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse) 
2023-01-05 | PXD039272 | Pride
Prostate cancer Trop2 Xenograft Mice 
ProteomicsSU086 Treatment for Advanced Prostate Cancer
We tested a novel small molecule, SU086, as a therapeutic strategy for advanced prostate cancer. Proteomic analysis was performed on treated cell lines and controls to identify protein differences. Cellular thermal shift assay (CETSA) was used to determine the interaction of SU086 with proteins.
ORGANISM(S): Homo sapiens (Human) 
2022-04-01 | PXD030524 | Pride
Prostate cancer Cell lines Cetsa Lc-ms/ms 
UnknownPerspectives on ENCODE.
Not available
S-EPMC7410827 | biostudies-literature
UnknownExpanded encyclopaedias of DNA elements in the human and mouse genomes.
Not available
S-EPMC7410828 | biostudies-literature
Sort   by:  
 Page size